|
1
|
Li P, Liu H, Wang Z, He F, Wang H, Shi Z,
Yang A and Ye J: MicroRNAs in laryngeal cancer: Implications for
diagnosis, prognosis and therapy. Am J Transl Res. 8:1935–1944.
2016.PubMed/NCBI
|
|
2
|
Gama RR, Carvalho AL, Filho Longatto A,
Scorsato AP, López RV, Rautava J, Syrjänen S and Syrjänen K:
Detection of human papillomavirus in laryngeal squamous cell
carcinoma: Systematic review and meta-analysis. Laryngoscope.
126:885–893. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greco A, Rizzo MI, De Virgilio A, Gallo A,
Fusconi M, Pagliuca G, Martellucci S, Turchetta R and De Vincentiis
M: Cancer stem cells in laryngeal cancer: What we know. Eur Arch
Otorhinolaryngol. 273:3487–3495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang CY and Lin CF: Annexin A2: Its
molecular regulation and cellular expression in cancer development.
Dis Markers. 2014:3089762014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo C, Liu S and Sun MZ: Potential role of
Anxa1 in cancer. Future Oncol. 9:1773–1793. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu N, Liu S, Guo C, Hou Z and Sun MZ: The
role of Annexin A3 playing in cancers. Clin Transl Oncol.
15:106–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alves VA, Nonogaki S, Cury PM,
Wünsch-Filho V, de Carvalho MB, Michaluart-Júnior P, Moyses RA,
Curioni OA, Figueiredo DL, Scapulatempo-Neto C, et al: Annexin A1
subcellular expression in laryngeal squamous cell carcinoma.
Histopathology. 53:715–727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang KL, Wu TT, Resetkova E, Wang H,
Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton
SR and Albarracin CT: Expression of annexin A1 in esophageal and
esophagogastric junction adenocarcinomas: Association with poor
outcome. Clin Cancer Res. 12:4598–4604. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Guo B, Zhang Y, Cao J and Chen T:
Silencing of the annexin II gene down-regulates the levels of
S100A10, c-Myc, and plasmin and inhibits breast cancer cell
proliferation and invasion. Saudi Med J. 31:374–381.
2010.PubMed/NCBI
|
|
10
|
Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen
F, Zhao YZ and Fu SB: Involvement of Annexin A2 in p53 induced
apoptosis in lung cancer. Mol Cell Biochem. 309:117–123. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng S, Wang J, Hou L, Li J, Chen G, Jing
B, Zhang X and Yang Z: Annexin A1, A2, A4 and A5 play important
roles in breast cancer, pancreatic cancer and laryngeal carcinoma,
alone and/or synergistically. Oncol Lett. 5:107–112.
2013.PubMed/NCBI
|
|
12
|
Yang J, Zhou M, Zhao R, Peng S, Luo Z, Li
X, Cao L, Tang K, Ma J, Xiong W, et al: Identification of candidate
biomarkers for the early detection of nasopharyngeal carcinoma by
quantitative proteomic analysis. J Proteomics. 109:162–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo Y, Wang X, Wang H, Xu Y, Wen Q, Fan S,
Zhao R, Jiang S, Yang J, Liu Y, et al: High Bak Expression Is
Associated with a Favorable Prognosis in Breast Cancer and
Sensitizes Breast Cancer Cells to Paclitaxel. PLoS One.
10:e1389552015. View Article : Google Scholar
|
|
14
|
Thompson LD: Laryngeal dysplasia, squamous
cell carcinoma, and variants. Surg Pathol Clin. 10:15–33. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mannelli G, Cecconi L and Gallo O:
Laryngeal preneoplastic lesions and cancer: Challenging diagnosis.
Qualitative literature review and meta-analysis. Crit Rev Oncol
Hematol. 106:64–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu XH, Pan W, Kang LH, Feng H and Song YQ:
Association of annexin A2 with cancer development (Review). Oncol
Rep. 33:2121–2128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lauritzen SP, Boye TL and Nylandsted J:
Annexins are instrumental for efficient plasma membrane repair in
cancer cells. Semin Cell Dev Biol. 45:32–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Liu S, Guo C, Zong J and Sun MZ:
The association of annexin A2 and cancers. Clin Transl Oncol.
14:634–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El-Abd N, Fawzy A, Elbaz T and Hamdy S:
Evaluation of annexin A2 and as potential biomarkers for
hepatocellular carcinoma. Tumour Biol. 37:211–216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Yao M, Wu W, Qiu L, Sai W, Yang
J, Zheng W, Huang J and Yao D: Up-regulation of annexin A2
expression predicates advanced clinicopathological features and
poor prognosis in hepatocellular carcinoma. Tumour Biol.
36:9373–9383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lokman NA, Pyragius CE, Ruszkiewicz A,
Oehler MK and Ricciardelli C: Annexin A2 and S100A10 are
independent predictors of serous ovarian cancer outcome. Transl
Res. 171:83–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen CY, Lin YS, Chen CL, Chao PZ, Chiou
JF, Kuo CC, Lee FP, Lin YF, Sung YH, Lin YT, et al: Targeting
annexin A2 reduces tumorigenesis and therapeutic resistance of
nasopharyngeal carcinoma. Oncotarget. 6:26946–26959. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng L, Gao Y, Li X, Cai M, Wang H, Zhuang
H, Tan M, Liu S, Hao Y and Lin B: Expression and clinical
significance of annexin A2 and human epididymis protein 4 in
endometrial carcinoma. J Exp Clin Cancer Res. 34:962015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu H, Zhao J and Zhang M: Expression of
annexin A2 and its correlation with drug resistance and recurrence
of bladder cancer. Technol Cancer Res Treat. 15:NP61–NP68. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi CH, Chung JY, Chung EJ, Sears JD, Lee
JW, Bae DS and Hewitt SM: Prognostic significance of annexin A2 and
annexin A4 expression in patients with cervical cancer. BMC Cancer.
16:4482016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu CM, Lin JJ, Huang HH, Ko YC, Hsu JL,
Chen JC, Din ZH and Wu YJ: A panel of tumor markers, calreticulin,
annexin A2, and annexin A3 in upper tract urothelial carcinoma
identified by proteomic and immunological analysis. BMC Cancer.
14:3632014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang CY, Chen CL, Tseng YL, Fang YT, Lin
YS, Su WC, Chen CC, Chang KC, Wang YC and Lin CF: Annexin A2
silencing induces G2 arrest of non-small cell lung cancer cells
through p53-dependent and -independent mechanisms. J Biol Chem.
287:32512–32524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Zheng S, Liu Q, Liu T, Liang M, Gao
X, Lu M, Sheyhidin I and Lu X: Under-expression of annexin A2 is
associated with Kazakh's esophageal squamous cell carcinoma. Mol
Carcinog. 54:779–788. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang SF, Hsu HL, Chao TK, Hsiao CJ, Lin YF
and Cheng CW: Annexin A2 in renal cell carcinoma: Expression,
function, and prognostic significance. Urol Oncol. 33:222015.
View Article : Google Scholar : PubMed/NCBI
|
